Experiences with a 3-monthly injections of medroxyprogesterone acetate (MPA) as a contraceptive agent
Linthorst, G.; Wibaut, E.P.; de Jongh, R.E.
Nederlands Tijdschrift Voor Geneeskunde 116(38): 1694-1698
1972
ISSN/ISBN: 0028-2162 PMID: 5069858 Document Number: 55702
Document emailed within 1 workday
Related Documents
Melo, J.F.; Coutinho, E.M. 1977: Inhibition of spermatogenesis in men with monthly injections of medroxyprogesterone acetate and testosterone enanthate Contraception 15(6): 627-634Thurman, A.; Kimble, T.; Hall, P.; Schwartz, J.L.; Archer, D.F. 2013: Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics Contraception 87(6): 738-743
Canto de Cetina, T.E.; Luna, M.Ordoñez.; Cetina Canto, Jé.Antonio.; Bassol, S. 2004: Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections Contraception 69(2): 115-119
Harel, Z.; Johnson, C.Cole.; Gold, M.A.; Cromer, B.; Peterson, E.; Burkman, R.; Stager, M.; Brown, R.; Bruner, A.; Coupey, S.; Hertweck, P.; Bone, H.; Wolter, K.; Nelson, A.; Marshall, S.; Bachrach, L.K. 2010: Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections Contraception 81(4): 281-291
Powell, L.C.; Seymour, R.J. 1971: Effects of depo-medroxyprogesterone acetate as a contraceptive agent American Journal of Obstetrics and Gynecology 110(1): 36-41
Soichet, S. 1969: Depo-provera (medroxyprogesterone acetate) as a female contraceptive agent International Journal of Fertility 14(1): 33-38
Mettler, L.; Shirwani, D.; Brunnberg, F.J. 1979: Thombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent Journal of Postgraduate Medicine 25(3): 154-157
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Brat, T.; Decoster, J.M.; Molitor-Peffer, M.P. 1979: Six-monthly administration of medroxyprogesterone acetate (MPA) Journal de Gynecologie Obstetrique et Biologie de la Reproduction 8(7): 659-662
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Jeppsson, S. 1972: Experience with depo-medroxyprogesterone acetate (Depo-Provera) as a contraceptive agent Acta Obstetricia et Gynecologica Scandinavica 51(3): 257-263
Frick, J.; Bartsch, G.; Weiske, W.H. 1977: The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels Contraception 15(6): 649-668
Frick, J.; Bartsch, G.; Weiske, W.H. 1977: The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. II. High initial dose Contraception 15(6): 669-677
Jeppsson, S.; Gershagen, S.; Johansson, E. D. B.; Rannevik, G. 1982: Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera(R)) as a contraceptive agent European Journal of Endocrinology 99(3): 339-343
Tomasicchio, M.; Avenant, C.; Du Toit, A.; Ray, R.M.; Hapgood, J.P. 2013: The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor PLOS one 8(5): E62895
Govender, Y.; Avenant, C.; Verhoog, N.J.D.; Ray, R.M.; Grantham, N.J.; Africander, D.; Hapgood, J.P. 2014: The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor Plos one 9(5): E96497
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405
Bloch, B. 1971: Depot medroxyprogesterone acetate (Depo-Provera) as a contraceptive preparation South African Medical Journal 45(28): 777-780
Jawalekar, K.S.; Chitale, M.V. 1973: Medroxyprogesterone acetate as an injectable contraceptive--its utility in Indian women Journal of Obstetrics and Gynaecology of India 23(1): 55-57